• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

    39.88 +0.02 (+0.05%)
    Streaming Delayed Price Updated: 1:20 PM EDT, Jun 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 607,726
    Open 39.81
    Bid (Size) 39.88 (700)
    Ask (Size) 39.89 (500)
    Prev. Close 39.86
    Today's Range 39.76 - 39.98
    52wk Range 10.95 - 40.26
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Halper Sadeh LLC is Investigating Whether RAMP, NEE, CNTA, GDOT are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
    From Kahn Swick & Foti, LLC
    Via Business Wire

    Performance

    YTD
    +68.3%
    +68.3%
    1 Month
    +0.5%
    +0.5%
    3 Month
    +50.4%
    +50.4%
    6 Month
    +40.1%
    +40.1%
    1 Year
    +197.4%
    +197.4%

    More News

    Read More
    News headline image
    Forget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli Lilly ↗
    Via The Motley Fool
    News headline image
    Is This $6.3 Billion Deal a Game Changer for Eli Lilly? ↗
    Via The Motley Fool
    News headline image
    Looks Like M&A Week in 3 Different Sectors ↗
    Via The Motley Fool
    News headline image
    Halper Sadeh LLC is Investigating Whether APLS, CNTA, KZR, EQH are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
    From Ademi LLP
    Via GlobeNewswire
    News headline image
    Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep Market’s ‘Orexin Gold Rush’
    Via MarketMinute
    News headline image
    Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
    Via MarketMinute
    Topics Artificial Intelligence
    News headline image
    Lilly's Next Empire: A $10 Billion Bet on AI and Neuroscience ↗
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    Halper Sadeh LLC is Investigating Whether APLS, CNTA, EQH, VYNE are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    Wall Street Ends a Rough Quarter With Its Best Day, Iran Hope Ignites the Rally ↗
    Via Chartmill
    News headline image
    Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Why Centessa Stock Soared Today ↗
    Via The Motley Fool
    News headline image
    Halper Sadeh LLC is Investigating Whether APLS, CNTA, BIRD, WBD are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Which stocks are experiencing notable movement on Tuesday? ↗
    Via Chartmill
    The market is filled with gapping stocks in Tuesday's session. ↗
    Via Chartmill
    News headline image
    The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals
    Via Finterra
    Topics Economy Initial Public Offering Intellectual Property
    News headline image
    The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
    Via Finterra
    Topics Economy Intellectual Property
    Discover the top movers in Tuesday's pre-market session. ↗
    Via Chartmill
    News headline image
    CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline ↗
    Via The Motley Fool
    News headline image
    Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Centessa Pharmaceuticals plc - American Depositary Shares publicly traded?
    Yes, Centessa Pharmaceuticals plc - American Depositary Shares is publicly traded.
    What exchange does Centessa Pharmaceuticals plc - American Depositary Shares trade on?
    Centessa Pharmaceuticals plc - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares?
    The ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares is CNTA on the Nasdaq Stock Market
    What is the current price of Centessa Pharmaceuticals plc - American Depositary Shares?
    The current price of Centessa Pharmaceuticals plc - American Depositary Shares is 39.88
    When was Centessa Pharmaceuticals plc - American Depositary Shares last traded?
    The last trade of Centessa Pharmaceuticals plc - American Depositary Shares was at 06/02/26 01:20 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.